Mangrove Partners Geron Corp Transaction History
Mangrove Partners
- $642 Million
- Q4 2024
A detailed history of Mangrove Partners transactions in Geron Corp stock. As of the latest transaction made, Mangrove Partners holds 166,700 shares of GERN stock, worth $303,394. This represents 0.02% of its overall portfolio holdings.
Number of Shares
166,700Holding current value
$303,394% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GERN
# of Institutions
307Shares Held
465MCall Options Held
1.07MPut Options Held
648K-
Black Rock Inc. New York, NY46.6MShares$84.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$61 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$54.6 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$49.6 Million18.81% of portfolio
-
State Street Corp Boston, MA27.2MShares$49.4 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $688M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...